Medicinal product name MabThera
Pharmaceutical form Solution for injection
Strength 1400 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/98/067/003 KZSLN1 Is available
Legal status Rx Prescription (Pr.)
KZSL Next lowest cost medicine
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresIzglītojošie materiāli ārstam Izglītojošie materiāli ārstam
Izglītojošie materiāli pacientam Izglītojošie materiāli pacientam
ATC code L01FA01 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(42 containers)
Roche Latvija N1
(1400 mg/11,7 ml)
Glass vial 2094.43 
KZSL*
EU/1/98/067/003  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/98/067/003
Date of authorisation Jun 2, 1998
Marketing authorisation holder, country Roche Registration GmbH, Germany